InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
3
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Rosenblum Mark J, 首席财务官. Officer active across 1 company, notably Salarius Pharmaceuticals, Inc.. Aggregated, 11 disclosures have been published. Split: 3 buys · 0 sell. Total volume traded: €45k. Activity tracked since 3 May 2021. The latest transaction was filed on 20 November 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Rosenblum Mark J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
20,000 股@ US$0.8016.3% 占其流量Common StockSEC:0001615219-25-000177:0
标准退出：2026年2月18日 (T+90)
6,432 股0Common StockSEC:0001615219-23-000025:0
8,000 股0Common StockSEC:0001615219-23-000004:0
1,488 股@ US$1.7343.3% 占其流量Common StockSEC:0001615219-22-000153:0
7,314 股@ US$1.73416.1% 占其流量Common StockSEC:0001615219-22-000143:0
7,314 股@ US$1.73416.1% 占其流量Common StockSEC:0001615219-22-000141:0
28,000 股@ US$0.189.0% 占其流量Common StockSEC:0001615219-22-000085:0
标准退出：2022年8月29日 (T+90)
10,000 股@ US$0.18633.4% 占其流量Common StockSEC:0001615219-22-000067:0
76,246 股@ US$0.39151.7% 占其流量Common StockSEC:0001615219-22-000019:0
标准退出：2022年6月1日 (T+90)
7,787 股@ US$0.7186.7% 占其流量Common StockSEC:0001615219-21-000095:0
9,563 股@ US$0.5675.3% 占其流量Common StockSEC:0001615219-21-000042:0
11 条申报中的 11 条
About Rosenblum Mark J
Mark J. Rosenblum is Executive Vice President and Chief Financial Officer at Salarius Pharmaceuticals, Inc. He oversees the financial operations of the company, ensuring effective resource management and contributing to financial strategy. His role is essential for the financial health of the organization.
